Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Haemostatic abnormalities and thyroid disorders: the prospective observational MITH study].

Recenti progressi in medicina·2014
Same author

[Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].

Recenti progressi in medicina·2013
Same author

Canine olfactory detection of cancer versus laboratory testing: myth or opportunity?

Clinical chemistry and laboratory medicine·2011
Same author

Unusual false-positive case of urinary screening for buprenorphine.

Journal of clinical laboratory analysis·2011
Same author

From music-beat to heart-beat: a journey in the complex interactions between music, brain and heart.

European journal of internal medicine·2011
Same author

Prehospital qualitative troponin measurement: is it really worthwhile and needed?

The American journal of cardiology·2011

Related Experiment Video

Updated: Jun 24, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Thyroid-associated autoimmune coagulation disorders.

Massimo Franchini1, Giuseppe Lippi, Franco Manzato

  • 1Servizio di Immunoematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy. massimo.franchini@azosp.vr.it

Journal of Thrombosis and Thrombolysis
|March 12, 2009
PubMed
Summary
This summary is machine-generated.

Thyroid dysfunction can cause autoimmune coagulation disorders, including autoimmune thrombocytopenic purpura and antiphospholipid syndrome. Early detection is crucial for effective patient management.

Related Experiment Videos

Last Updated: Jun 24, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Endocrinology
  • Hematology
  • Immunology

Background:

  • Thyroid dysfunction is frequently associated with coagulation abnormalities, ranging from mild to severe bleeding or clotting issues.
  • Autoimmune coagulation disorders can manifest in patients with thyroid diseases, impacting their clinical outcomes.

Purpose of the Study:

  • To review current knowledge on thyroid-associated autoimmune coagulation disorders.
  • To discuss laboratory features, clinical significance, and pathogenesis of these conditions.
  • To emphasize the importance of timely diagnosis for patient management.

Main Methods:

  • Literature review of studies on thyroid disorders and autoimmune coagulation abnormalities.
  • Synthesis of information on laboratory characteristics, clinical impact, and pathogenesis.
  • Analysis of recent advancements in understanding the underlying mechanisms.

Main Results:

  • Thyroid dysfunction is linked to autoimmune thrombocytopenic purpura, antiphospholipid syndrome, and anti-factor VIII antibodies.
  • These disorders present with diverse laboratory findings and can lead to significant hemorrhagic or thrombotic events.
  • Recent research has shed light on the complex pathogenesis of these associated conditions.

Conclusions:

  • Prompt recognition of autoimmune coagulation disorders in thyroid patients is essential.
  • Integrated management strategies are necessary for patients with concomitant thyroid dysfunction and coagulation abnormalities.
  • Further research into pathogenesis may improve diagnostic and therapeutic approaches.